• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT CRM S.R.L. PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT CRM S.R.L. PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION Back to Search Results
Model Number PLATINIUM 4LV SONR CRT-D 1844
Device Problem Inappropriate/Inadequate Shock/Stimulation (1574)
Patient Problems No Information (3190); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2020
Event Type  malfunction  
Manufacturer Narrative
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by sorin that was cleared or approved by fda for marketing in the united states.
 
Event Description
On (b)(6) 2017, the defibrillation system was implanted.Reportedly, during a follow-up on (b)(6) 2020, a shock therapy was observed on (b)(6) 2020.According to the physician, the shock is suspected to be inappropriate, as the patient was in an atrial fibrillation during almost the whole day.The clinical record of the patient was reviewed because vvi mode at 40 min-1 was programmed for an unknown reason.Reportedly the patient¿s condition worsened after the implantation, with a qrs length of 158 ms, which was longer with pacing than without pacing.It was also observed that no markers were recorded in the device memories for the shock nor for the atp therapy.Only the markers for the charges were observed.
 
Event Description
On (b)(6) 2017, the defibrillation system was implanted.Reportedly, during a follow-up on (b)(6) 2020, a shock therapy was observed on (b)(6) 2020.According to the physician, the shock is suspected to be inappropriate, as the patient was in an atrial fibrillation during almost the whole day.The clinical record of the patient was reviewed because vvi mode at 40 min-1 was programmed for an unknown reason.Reportedly the patient's condition worsened after the implantation, with a qrs length of 158 ms, which was longer with pacing than without pacing.It was also observed that no markers were recorded in the device memories for the shock nor for the atp therapy.Only the markers for the charges were observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLATINIUM
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION
Manufacturer (Section D)
MICROPORT CRM S.R.L.
via crescentino s.n.
saluggia (vc), 13040
IT  13040
MDR Report Key11141528
MDR Text Key227486128
Report Number1000165971-2021-00214
Device Sequence Number1
Product Code NIK
UDI-Device Identifier08031527014524
UDI-Public(01)08031527014524(11)170612(17)190112
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/12/2019
Device Model NumberPLATINIUM 4LV SONR CRT-D 1844
Device Catalogue NumberPLATINIUM 4LV SONR CRT-D 1844
Device Lot NumberS0267
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/14/2020
Event Location Hospital
Date Manufacturer Received03/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-